NEOS Investment Management LLC Has $8.25 Million Position in HCA Healthcare, Inc. $HCA

NEOS Investment Management LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,363 shares of the company’s stock after buying an additional 2,549 shares during the quarter. NEOS Investment Management LLC’s holdings in HCA Healthcare were worth $8,253,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth $1,021,000. NewEdge Advisors LLC grew its stake in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Stephens Inc. AR raised its holdings in HCA Healthcare by 3.2% in the 2nd quarter. Stephens Inc. AR now owns 8,500 shares of the company’s stock worth $3,256,000 after purchasing an additional 265 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale boosted its holdings in shares of HCA Healthcare by 2.4% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 98,819 shares of the company’s stock valued at $37,318,000 after buying an additional 2,313 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 in the last three months. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $534.88 on Thursday. The stock has a market cap of $119.61 billion, a price-to-earnings ratio of 18.85, a PEG ratio of 1.64 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $552.90. The firm’s 50-day moving average is $486.13 and its two-hundred day moving average is $452.76.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the prior year, the business posted $6.22 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is presently 10.15%.

Analysts Set New Price Targets

HCA has been the subject of a number of analyst reports. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. The Goldman Sachs Group lifted their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Bank of America raised their price objective on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Finally, Barclays upped their price objective on HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $523.27.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA opened a second freestanding emergency room in a Florida county (St. Augustine), expanding local access and potential outpatient/ER revenue streams as the company pushes more care into lower-acuity, higher-margin settings. Becker’s: HCA opens 2nd freestanding ER in Florida county MSN: HCA Florida Emergency opens for patients in St. Augustine
• Positive Sentiment: An HCA subsidiary acquired a cardiothoracic and vascular physician group, a deal that should boost patient referrals into HCA hospitals, increase capture of surgical volume, and support revenue growth in high-acuity service lines. Becker’s: HCA subsidiary acquires cardiothoracic, vascular physician group
• Positive Sentiment: HCA is investing in EHR unification (alongside peers), an initiative that can lower IT/operational costs, improve care coordination and billing efficiencies — all supportive of margins over time. Becker’s: Why Northwell, HCA and UPMC are betting big on EHR unification
• Positive Sentiment: Analyst/style coverage and positive momentum stories (Zacks, Kalkine) highlight HCA as a value/momentum name, which can attract income/value-oriented and momentum-driven flows. Zacks: Here’s Why HCA Healthcare is a Strong Value Stock Kalkine: HCA Momentum Shines
• Neutral Sentiment: Discussion pieces and analyst roundups examine where HCA shares may head next; these provide context but are unlikely to move the stock materially absent new guidance or earnings surprises. Yahoo Finance: Are Wall Street Analysts Predicting HCA Stock Will Climb or Sink?
• Neutral Sentiment: Local community/CSR activity (National Wear Red Day with Habitat for Humanity) is positive for brand and community relations but has limited direct impact on near-term financials. Post and Courier: HCA marks National Wear Red Day
• Negative Sentiment: An HCA EVP, Michael R. McAlevey, disclosed a sale of 1,694 shares for about $903k, reducing his holdings ~16% — insider selling can signal personal liquidity needs but may create short-term negative sentiment for investors reading into insider actions. SEC filing: SEC filing: Insider sale

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.